Commentary.

The article comments on the use of atypical antipsychotic drugs in treating people with dementia. Increase on the risk of stroke and death may be associated with the administration of atypical antipsychotic drugs but the validity of such claim has been tainted with doubt. However, with the recent clinical trials conducted, a solid evidence was found out. Physicians therefore should consider the benefits and the risk associated with these drugs before prescribing them.